High Outlier

Strength

12; .25 mg/g; mg/g

NDC

99207030030

Classification

Brand

Dosage Form

GEL

Route

TOPICAL

Last Updated

2/18/2015

Approval Type

New Drug (NDA)

FDA Application

NDA050802

On Market Since

12/1/2006

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade
Retinoid
Retinoids

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+24.5%